Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 629.37M | 640.49M | 640.51M | 642.44M | 646.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 629.37M | 640.49M | 640.51M | 642.44M | 646.13M |
| Cost of Revenue | 196.83M | 188.93M | 179.75M | 188.06M | 194.54M |
| Gross Profit | 432.54M | 451.56M | 460.76M | 454.39M | 451.59M |
| SG&A Expenses | 329.65M | 327.45M | 339.17M | 330.26M | 349.39M |
| Depreciation & Amortization | 87.87M | 89.52M | 89.57M | 96.57M | 97.89M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 684.31M | 682.65M | 680.87M | 691.64M | 723.21M |
| Operating Income | -54.94M | -42.16M | -40.36M | -49.19M | -77.08M |
| Income Before Tax | -111.27M | -48.17M | -32.50M | -833.79M | -79.20M |
| Income Tax Expenses | -18.26M | 238.00K | 780.00K | 3.88M | 2.69M |
| Earnings from Continuing Operations | -93.01M | -48.41M | -33.28M | -837.67M | -81.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -93.01M | -48.41M | -33.28M | -837.67M | -81.89M |
| EBIT | -54.94M | -42.16M | -40.36M | -49.19M | -77.08M |
| EBITDA | -8.96M | 11.78M | 13.39M | 16.61M | -10.06M |
| EPS Basic | -0.53 | -0.28 | -0.19 | -4.92 | -0.49 |
| Normalized Basic EPS | -0.16 | -0.15 | -0.10 | -0.15 | -0.26 |
| EPS Diluted | -0.53 | -0.28 | -0.19 | -4.92 | -0.49 |
| Normalized Diluted EPS | -0.16 | -0.15 | -0.10 | -0.15 | -0.26 |
| Average Basic Shares Outstanding | 174.15M | 172.77M | 171.50M | 170.23M | 167.73M |
| Average Diluted Shares Outstanding | 174.15M | 172.77M | 171.50M | 170.23M | 167.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |